Research ArticleOMERACT 12 — International Consensus Conference on Outcome Measures in Rheumatology, Budapest, Hungary, May 7–11, 2014
Exploration, Development, and Validation of Patient-reported Outcomes in Antineutrophil Cytoplasmic Antibody–associated Vasculitis Using the OMERACT Process
Joanna C. Robson, Nataliya Milman, Gunnar Tomasson, Jill Dawson, Peter F. Cronholm, Katherine Kellom, Judy Shea, Susan Ashdown, Maarten Boers, Annelies Boonen, George C. Casey, John T. Farrar, Don Gebhart, Jeffrey Krischer, Georgia Lanier, Carol A. McAlear, Jacqueline Peck, Antoine G. Sreih, Peter S. Tugwell, Raashid A. Luqmani and Peter A. Merkel
The Journal of Rheumatology November 2015, 42 (11) 2204-2209; DOI: https://doi.org/10.3899/jrheum.141143
Joanna C. Robson
From the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Science, University of Oxford, Oxford,
UK; Division of Rheumatology, University of Ottawa, Ottawa, Ontario,
Canada; Department of Public Health Sciences, University of Iceland, Reykjavik,
Iceland; Nuffield Department of Population Health (HSRU), University of Oxford, Oxford,
UK; Department of Family Medicine and Community Health, and Division of Rheumatology and Department of Biostatistics and Epidemiology, University of Pennsylvania, and Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania,
USA; Departments of Epidemiology and Biostatistics; and Rheumatology, VU University Medical Center, Amsterdam, The
Netherlands; Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, University Maastricht, Maastricht,
The Netherlands; Vasculitis Foundation, Denver, Colorado,
USA; Division of Biostatistics and Informatics, Department of Pediatrics, College of Medicine, University of South Florida, Tampa, Florida,
USA; Vasculitis Clinical Research Consortium, and Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania,
USA.
Nataliya Milman
Gunnar Tomasson
Jill Dawson
Peter F. Cronholm
Katherine Kellom
Judy Shea
Susan Ashdown
Maarten Boers
Annelies Boonen
George C. Casey
John T. Farrar
Don Gebhart
Jeffrey Krischer
Georgia Lanier
Carol A. McAlear
Jacqueline Peck
Antoine G. Sreih
Peter S. Tugwell
Raashid A. Luqmani
Peter A. Merkel
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 42, Issue 11
1 Nov 2015
Exploration, Development, and Validation of Patient-reported Outcomes in Antineutrophil Cytoplasmic Antibody–associated Vasculitis Using the OMERACT Process
Joanna C. Robson, Nataliya Milman, Gunnar Tomasson, Jill Dawson, Peter F. Cronholm, Katherine Kellom, Judy Shea, Susan Ashdown, Maarten Boers, Annelies Boonen, George C. Casey, John T. Farrar, Don Gebhart, Jeffrey Krischer, Georgia Lanier, Carol A. McAlear, Jacqueline Peck, Antoine G. Sreih, Peter S. Tugwell, Raashid A. Luqmani, Peter A. Merkel
The Journal of Rheumatology Nov 2015, 42 (11) 2204-2209; DOI: 10.3899/jrheum.141143
Exploration, Development, and Validation of Patient-reported Outcomes in Antineutrophil Cytoplasmic Antibody–associated Vasculitis Using the OMERACT Process
Joanna C. Robson, Nataliya Milman, Gunnar Tomasson, Jill Dawson, Peter F. Cronholm, Katherine Kellom, Judy Shea, Susan Ashdown, Maarten Boers, Annelies Boonen, George C. Casey, John T. Farrar, Don Gebhart, Jeffrey Krischer, Georgia Lanier, Carol A. McAlear, Jacqueline Peck, Antoine G. Sreih, Peter S. Tugwell, Raashid A. Luqmani, Peter A. Merkel
The Journal of Rheumatology Nov 2015, 42 (11) 2204-2209; DOI: 10.3899/jrheum.141143